IL6 and liver cancer: Our data demonstrate that in hepatic cancer cell lines APE1 redox function is involved in TNF-α and FA-induced IL-8- and IL-6 expression, and its inhibition by E3330 may represent a promising tool for reducing the early inflammatory process in liver diseases such as in NASH.